5PSQ-057 Efficacy and safety of adalimumab in the treatment of inflammatory facial granuloma secondary to silicone | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 5: Patient safety and quality assurance

5PSQ-057 Efficacy and safety of adalimumab in the treatment of inflammatory facial granuloma secondary to silicone

Free

Online download statistics by month:

Online download statistics by month: March 2023 to August 2024

	Abstract	Full	Pdf
Mar 2023	14	0	1
Apr 2023	92	0	18
May 2023	107	0	18
Jun 2023	26	0	2
Jul 2023	36	0	6
Aug 2023	19	0	0
Sep 2023	12	0	6
Oct 2023	7	0	0
Nov 2023	9	0	3
Dec 2023	21	0	4
Jan 2024	3	0	0
Feb 2024	14	0	1
Mar 2024	15	0	8
Apr 2024	9	0	3
May 2024	12	0	0
Jun 2024	8	0	2
Jul 2024	5	0	4
Aug 2024	7	0	6
Total	416	0	82